Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enlicitide Decanoate in Adults With Hyperlipidemia in India
NCT07821944Phase 3Recruiting
- Sponsor
- Merck & Co.
- Start
- Oct 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
A Phase 3 trial of enlicitide in hyperlipidemia, hypercholesterolemia, sponsored by Merck & Co.. Started Oct 2026; status: recruiting.
02
Drugs
enlicitide
03
Conditions
hyperlipidemiahypercholesterolemia
Beyond the preview
Go deeper on NCT07821944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07821944.